NCT04158336 2026-03-18
A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 1 Completed
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
BeOne Medicines
Prisma Health-Upstate
Children's National Research Institute
M.D. Anderson Cancer Center
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
Novartis
Chugai Pharmaceutical
Anhui Provincial Cancer Hospital
Sichuan Huiyu Pharmaceutical Co., Ltd
Georgetown University
Salubris Biotherapeutics Inc
Peking University Cancer Hospital & Institute
Eisai Inc.
St. Jude Children's Research Hospital
Zhejiang University